Safety and Tolerability of Secukinumab in Patients with Active Ankylosing Spondylitis: Pooled Safety Analysis of Two Phase 3, Randomized, Controlled Trials

被引：0
|
作者：
Deodhar, Atul A. [1 ]
Baeten, Dominique [2 ]
Sieper, Joachim [3 ]
Porter, Brian [4 ]
Widmer, Albert [5 ]
Richards, Hanno [5 ]
机构：
[1] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA
[2] Univ Amsterdam, Acad Med Ctr, Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Clin Benjamin Franklin, Berlin, Germany
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] Novartis Pharma AG, Basel, Switzerland
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
SIGNIFICANTLY IMPROVES SIGNS; PLACEBO-CONTROLLED TRIAL; MONOCLONAL-ANTIBODY; INTERLEUKIN-17A; SYMPTOMS; PHASE-3;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2887
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Tolerability, safety, and efficacy of adjunctive brivaracetam for focal seizures in older patients: A pooled analysis from three phase III studies
    Brodie, Martin J.
    Whitesides, John
    Schiemann, Jimmy
    D'Souza, Joseph
    Johnson, Martin E.
    EPILEPSY RESEARCH, 2016, 127 : 114 - 118
  • [42] Clinical Efficacy and Safety of Etanercept Versus Sulfasalazine in Patients With Ankylosing Spondylitis A Randomized, Double-Blind Trial
    Braun, Juergen
    van der Horst-Bruinsma, Irene E.
    Huang, Feng
    Burgos-Vargas, Ruben
    Vlahos, Bonnie
    Koenig, Andrew S.
    Freundlich, Bruce
    ARTHRITIS AND RHEUMATISM, 2011, 63 (06): : 1543 - 1551
  • [43] Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials
    Schoenfeld, P.
    Pimentel, M.
    Chang, L.
    Lembo, A.
    Chey, W. D.
    Yu, J.
    Paterson, C.
    Bortey, E.
    Forbes, W. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1161 - 1168
  • [44] Thyroid antibodies and levothyroxine effects in subclinical hypothyroidism: A pooled analysis of two randomized controlled trials
    Lyko, Christina
    Blum, Manuel R.
    Abolhassani, Nazanin
    Stuber, Mirah J.
    Del Giovane, Cinzia
    Feller, Martin
    Moutzouri, Elisavet
    Oberle, Jolanda
    Jungo, Katharina T.
    Collet, Tinh-Hai
    den Elzen, Wendy P. J.
    Poortvliet, Rosalinde K. E.
    Du Puy, Robert S.
    Dekkers, Olaf M.
    Trompet, Stella
    Jukema, J. Wouter
    Aujesky, Drahomir
    Quinn, Terry
    Westendorp, Rudi
    Kearney, Patricia M.
    Gussekloo, Jacobijn
    Van Heemst, Diana
    Mooijaart, Simon P.
    Bauer, Douglas C.
    Rodondi, Nicolas
    JOURNAL OF INTERNAL MEDICINE, 2022, 292 (06) : 892 - 903
  • [45] Efficacy and Safety of Linagliptin in 2681 Asian Patients Stratified by Age, Obesity, and Renal Function: A Pooled Analysis of Randomized Clinical Trials
    Ning, Guang
    Bandgar, Tushar
    Hehnke, Uwe
    Lee, Jisoo
    Chan, Juliana C. N.
    ADVANCES IN THERAPY, 2017, 34 (09) : 2150 - 2162
  • [46] The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials
    Lee, Young Ho
    Bae, Sang-Cheol
    Song, Gwan Gyu
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (11) : 1493 - 1499
  • [47] Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies
    Sandborn, William J.
    Feagan, Brian G.
    Danese, Silvio
    O'Brien, Christopher D.
    Ott, Elyssa
    Marano, Colleen
    Baker, Thomas
    Zhou, Yiying
    Volger, Sheri
    Tikhonov, Ilia
    Gasink, Christopher
    Sands, Bruce E.
    Ghosh, Subrata
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (07) : 994 - 1007
  • [48] SECUKINUMAB IMPROVES PHYSICAL FUNCTION AND QUALITY OF LIFE IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 2-YEAR DATA FROM MEASURE 1, A PHASE 3 RANDOMISED TRIAL
    Emery, P.
    Baeten, D.
    Deodhar, A.
    Wei, A.
    Geusens, P.
    Talloczy, Z.
    Gong, Y.
    Porter, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 818 - 818
  • [49] Efficacy and tolerability of zuranolone in patients with depression: a meta-analysis of randomized controlled trials
    Qiu, Youjia
    Tao, Yuchen
    Duan, Aojie
    Wei, Xingzhou
    Wang, Menghan
    Xie, Minjia
    Chen, Zhouqing
    Shang, Jing
    Wang, Zhong
    FRONTIERS IN PHARMACOLOGY, 2024, 14
  • [50] Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)
    Peter Nash
    Philip J. Mease
    Iain B. McInnes
    Proton Rahman
    Christopher T. Ritchlin
    Ricardo Blanco
    Eva Dokoupilova
    Mats Andersson
    Radhika Kajekar
    Shephard Mpofu
    Luminita Pricop
    Arthritis Research & Therapy, 20
12345